+1-888-308-5802     
News Contact Us

North America & Europe PEGylated Drugs Market Analysis By Emerging Growth Factors and Revenue Forecast To 2024

Author : Ronak Bora | Published Date : 2020-11-21 

North America & Europe PEGylated drugs market is projected to tread along a lucrative growth path. In addition to this, the rising acceptance of biologics drugs, including interferons, colony stimulating factors, and monoclonal antibodies, to treat chronic diseases would further boost the overall growth potential of this business space. There has been an evident increase in the number of cases of cancer in North America and Europe. According to the World Health Organization, Europe registers over 3.7 million new cases and 1.9 million deaths annually due to cancer. 

With the advent of enhanced medical therapies and innovative technologies, North America & Europe PEGylated drugs market has registered considerable gains in the past few years. The extensive proliferation of technology breakthroughs in the medical and healthcare devices sector has amplified the growth prospects across the space.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/2511

Investments made towards R&D by pharmaceutical giants along with the presence of various approved pegylated drugs will amplify the market growth. Increasing developments in biologics, favorable regulatory process along with efforts made to improve and design novel medication solutions are main factors supporting developments n the market.

With respect to the type, in the year 2017, colony-stimulating drugs gained considerable recognition due to the growing adoption of the granulocyte CSF, pegfilgrastin. Some of the advantages offered by the molecules include the reduction of the risk associated with neutropenia and infections that are caused due to bone marrow transplants or chemotherapy.

Industry players present in the region are working towards enhancing their products to meet the increasing demands of the pharmaceutical industry. In August 2020, the European Medicines Agency granted approval to the first drug towards curing of hepatitis D that may accompany and worsen the complications of hepatitis B.

This novel drug named Hepcludex has proven to suppress hepatitis D and hepatitis B virus. Some of the other notable companies operating in the market include Merck, Amgen, Pfizer, Sigma, UCB, and Pfizer, among numerous others.

Request for customization @ https://www.decresearch.com/roc/2511

Partial Chapter of the Table of Content

Chapter 4.  North America & Europe PEGylated Drugs Market, By Disease Indication

4.1. North America & Europe PEGylated drugs market share by disease indication, 2017 & 2024 

4.2. Cancer

4.2.1.  Market estimates and forecast, by country, 2013 - 2024 (USD Million)

4.3. Hepatitis 

4.3.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

4.4. Multiple sclerosis

4.4.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

4.5. Gastrointestinal disorders

4.5.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

4.6. Others

4.6.1.  Market estimates and forecast, by country, 2013 – 2024 (USD Million)

Chapter 5.  North America & Europe PEGylated Drugs, By Type

5.1. North America & Europe PEGylated drugs market share by type, 2017 & 2024 

5.2. Monoclonal antibodies (mAbs)

5.2.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)

5.3. Colony stimulating factors

5.3.1.  Market estimates and forecast, by country, 2013 - 2024 (USD Million)

5.4. Interferons

5.4.1.  Market estimates and forecast, by country, 2013 - 2024 (USD Million)

5.5. Others

5.5.1.  North America & Europe PEGylated drugs market estimates and forecast, by country, 2013 - 2024 (USD Million)

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/north-america-and-europe-pegylated-drugs-market

 

About Author

Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for fractovia and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport. [email protected] | https://twitter.com/RonakBora26

Related News

North America Aerospace Avionics Market to gain traction by 2025

Published Date: 2020-11-27         Author: Ronak Bora

The study on North America Aerospace Avionics Market provides a complete view on the industry with intricate details subject to its overall stance in the global landscape along with specifying various applications across major end-user sectors. North America aerospace avionics industry, as per the g... Read More

North America Aerospace Avionics Market to gain traction by 2025

Published Date: 2020-11-27         Author: Ronak Bora

... Read More

North America Biogas Market to amass significant gains by 2025

Published Date: 2020-11-27         Author: Ronak Bora

The market analysis on North America Biogas Market provides a holistic view on the overall industry along with laying significant focus on crucial details pertaining to its foothold in the global economy and its applications across multiple end-user industries and sectors. According to the given rep... Read More

© 2020 Fractovia. All Rights Reserved